INTRODUCTIONMidazolam is widely used nowadays for sedation during elective endoscopy. Its sedative effect is mediated by the γ‐aminobutyric acid neurotransmitter system. Midazolam binds to the benzodiazepine receptor ligand in the brain and its inhibitory function results in decreased muscle tone and reduced anxiety. It has a faster onset of action and a shorter duration of effect than other benzodiazepines.Flumazenil, a competitive benzodiazepine antagonist, can reverse the sedative and hypnotic effects of midazolam. It is well known that flumazenil has the effect of reversing benzodiazepine‐induced sedation and reducing recovery time. Therefore, the drug is frequently administered after endoscopy with midazolam sedation in clinical practice. Sometimes it is also used in routine procedures, especially if time, space and nursing resources are limited.The use of flumazenil to reverse midazolam sedation after endoscopy is generally believed to be safe. However, many of the studies were not randomized controlled trials (RCTs), or RCTs with a too small number of participants to reach significance and the sample size was not calculated. In addition, some studies have shown that the use of flumazenil can increase the risk of adverse effects in patients who are then admitted to the emergency ward with impaired consciousness due to benzodiazepine
Journal of Digestive Diseases – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera